Aleksandar Ivovic

Dr. Aleksandar Ivovic

University of Toronto

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ANAshraf Nahle
Ashraf Nahle
YJYemisi Deborah Joseph
Yemisi Deborah Joseph
SPSandra Pereira
Sandra Pereira
YMYusaku Mori
Yusaku Mori
FPFrankie Poon
Frankie Poon
Adria GiaccaAdria Giacca
Adria Giacca
The NAD-dependent deacetylase SIRT1 improves β cell function. Accordingly, nicotinamide mononucleotide (NMN), the product of the rate-limiting step in NAD synthesis, prevents β cell dysfunction and glucose intolerance in mice fed a high-fat diet. The current study was performed to assess the effects of NMN on β cell dysfunction and glucose intolerance that are caused specifically by increased circulating free fatty acids (FFAs). NMN was intravenously infused, with or without oleate, in C57BL/6J mice over a 48-h-period to elevate intracellular NAD levels and consequently increase SIRT1 activity. Administration of NMN in the context of elevated plasma FFA levels considerably improved glucose tolerance. This was due not only to partial protection from FFA-induced β cell dysfunction but also, unexpectedly, to a significant decrease in insulin clearance. However, in conditions of normal FFA levels, NMN impaired glucose tolerance due to decreased β cell function. The presence of this dual action of NMN suggests caution in its proposed therapeutic use in humans.

4 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
Justin Hou Ming YungJustin Hou Ming Yung
Justin Hou Ming Yung
LYLucy Shu Nga Yeung
Lucy Shu Nga Yeung
AIAleksandar Ivovic
Aleksandar Ivovic
YTYao Fang Tan
Yao Fang Tan
EJEmelien Mariella Jentz
Emelien Mariella Jentz
MMMortimer Mamelak
Mortimer Mamelak
Oxidative stress caused by the exposure of pancreatic ß-cells to high levels of fatty acids impairs insulin secretion. This lipotoxicity is thought to play an important role in ß-cell failure in type 2 diabetes and can be prevented by antioxidants. Gamma-hydroxybutyrate (GHB), an endogenous antioxidant and energy source, has previously been shown to protect mice from streptozotocin and alloxan-induced diabetes; both compounds are generators of oxidative stress and yield models of type-1 diabetes. We sought to determine whether GHB could protect mouse islets from lipotoxicity caused by palmitate, a model relevant to type 2 diabetes. We found that GHB prevented the generation of palmitate-induced reactive oxygen species and the associated lipotoxic inhibition of glucose-stimulated insulin secretion while increasing the NADPH/NADP+ ratio. GHB may owe its antioxidant and insulin secretory effects to the formation of NADPH.